Diagonal Bio AB (9F1)

Overview

Diagonal Bio AB (publ) distinguishes itself as a pioneering biotechnology enterprise based in Lund, Sweden. Since its establishment in 2020, the company has committed itself to the forefront of biotechnological innovation, specifically focusing on the realm of pathogen detection and diagnosis. The essence of their work lies in the development of the Panviral platform, a groundbreaking approach designed for the meticulous analysis and identification of pathogen genomes, encapsulating a wide array of microorganisms such as viruses, bacteria, and fungi. This innovative pursuit not only places Diagonal Bio AB at the cutting edge of biotechnology but also showcases their dedication to addressing and solving complex health challenges through advanced scientific methodologies.

Products and Services

• Panviral Platform

  This platform stands as the cornerstone of Diagonal Bio's offerings, designed with the objective to revolutionize the detection and diagnosis of pathogens. By targeting small, yet critical sections of genomes from a wide spectrum of microorganisms, the Panviral platform can identify viruses, bacteria, and fungi with high precision and efficiency. This cutting-edge technology offers profound implications for healthcare, particularly in the rapid and accurate diagnosis of infectious diseases, thereby facilitating timely and appropriate interventions.